York, U.K. 30 May 2022: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality and effective rapid tests, announces that it has signed a Testing
Abingdon Health PLC (AIM:ABDX) Significant contract to manufacture LFD components
Significant contract signed to manufacture lateral flow device components
Abingdon Health PLC (AIM:ABDX) Strategic collaboration with Bimelix Ab
Focused on the on development and commercialisation of Lyme disease lateral flow self-test
Abingdon Health PLC (AIM:ABDX) Completion of Technical Transfer & initial orders
Completion of Technical Transfer to full-scale manufacture and initial orders for Vatic KnowNowTM test
Abingdon Health PLC (ABDX.L) Update on AffiDX® SARS-CoV-2 antigen LFT
Technical transfer completed mid-December as planned
Abingdon Health PLC (ABDX.L) Preliminary Results
York, U.K. 18 November 2021: Abingdon Health plc (AIM: ABDX), a leading international developer and manufacturer of high quality and effective rapid tests, announces its preliminary results for the year
Abingdon Health PLC (ABDX.L) Launch of Semi-Quantitative Accessory to AbC-19T
To help indicate the strength of antibody response and possible immunity
Abingdon Health PLC (ABDX.L) Launch of BioSURE COVID-19 IgG Antibody Self Test
Contract manufacturing for CE marked self-test to monitor antibody status
TPI provides its latest research note on Midatech Pharma plc (MTPH.L)
Midatech has announced it has raised £10 million (gross) new funding through a UK equity placing (‘the Placing’) to new and existing UK investors at an issue price of 28.5p/share.
Immunodiagnostic Sys (IDH.L) Launch of SARS-CoV-2 Antigen Rapid Tests
Immunodiagnostic Systems Holdings plc (IDS), a specialty solution provider to the clinical laboratory diagnostic market, announces that two SARS-CoV-2 Antigen Rapid Test kits are now available for sale in the
TPI provides its latest research note on Scancell Holdings plc (SCLP.L).
The transformative phase of capital raising that Scancell has undertaken to date in 2020 now appears to have drawn to a close.